These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16940190)

  • 1. Both hepatic and extrahepatic ABCA1 have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels in vivo.
    Singaraja RR; Van Eck M; Bissada N; Zimetti F; Collins HL; Hildebrand RB; Hayden A; Brunham LR; Kang MH; Fruchart JC; Van Berkel TJ; Parks JS; Staels B; Rothblat GH; Fiévet C; Hayden MR
    Circulation; 2006 Sep; 114(12):1301-9. PubMed ID: 16940190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue ATP binding cassette transporter A1 contributes to high-density lipoprotein biogenesis in vivo.
    Chung S; Sawyer JK; Gebre AK; Maeda N; Parks JS
    Circulation; 2011 Oct; 124(15):1663-72. PubMed ID: 21931081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1.
    Wellington CL; Brunham LR; Zhou S; Singaraja RR; Visscher H; Gelfer A; Ross C; James E; Liu G; Huber MT; Yang YZ; Parks RJ; Groen A; Fruchart-Najib J; Hayden MR
    J Lipid Res; 2003 Aug; 44(8):1470-80. PubMed ID: 12730295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
    Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
    Timmins JM; Lee JY; Boudyguina E; Kluckman KD; Brunham LR; Mulya A; Gebre AK; Coutinho JM; Colvin PL; Smith TL; Hayden MR; Maeda N; Parks JS
    J Clin Invest; 2005 May; 115(5):1333-42. PubMed ID: 15841208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP-binding cassette transporter AI and its role in HDL formation.
    Lee JY; Parks JS
    Curr Opin Lipidol; 2005 Feb; 16(1):19-25. PubMed ID: 15650559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations.
    Basso F; Freeman L; Knapper CL; Remaley A; Stonik J; Neufeld EB; Tansey T; Amar MJ; Fruchart-Najib J; Duverger N; Santamarina-Fojo S; Brewer HB
    J Lipid Res; 2003 Feb; 44(2):296-302. PubMed ID: 12576511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic ATP-binding cassette transporter A1 is a key molecule in high-density lipoprotein cholesteryl ester metabolism in mice.
    Singaraja RR; Stahmer B; Brundert M; Merkel M; Heeren J; Bissada N; Kang M; Timmins JM; Ramakrishnan R; Parks JS; Hayden MR; Rinninger F
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1821-7. PubMed ID: 16728652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor.
    de Aguiar Vallim TQ; Tarling EJ; Kim T; Civelek M; Baldán Á; Esau C; Edwards PA
    Circ Res; 2013 Jun; 112(12):1602-12. PubMed ID: 23519696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterol.
    Post SM; Groenendijk M; van der Hoogt CC; Fievet C; Luc G; Hoekstra M; Princen HM; Staels B; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2724-30. PubMed ID: 17008588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of hepatic ABCA1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice.
    Ragozin S; Niemeier A; Laatsch A; Loeffler B; Merkel M; Beisiegel U; Heeren J
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1433-8. PubMed ID: 15845910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels.
    Brunham LR; Kruit JK; Pape TD; Parks JS; Kuipers F; Hayden MR
    Circ Res; 2006 Sep; 99(7):672-4. PubMed ID: 16946132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1.
    Francone OL; Subbaiah PV; van Tol A; Royer L; Haghpassand M
    Biochemistry; 2003 Jul; 42(28):8569-78. PubMed ID: 12859204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis.
    Feng Y; Lievens J; Jacobs F; Hoekstra M; Van Craeyveld E; Gordts SC; Snoeys J; De Geest B
    Cardiovasc Res; 2010 Nov; 88(2):376-85. PubMed ID: 20562425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.
    Kypreos KE; Zannis VI
    Biochem J; 2007 Apr; 403(2):359-67. PubMed ID: 17206937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocyte modulation of high-density lipoprotein cholesterol.
    Zhang Y; McGillicuddy FC; Hinkle CC; O'Neill S; Glick JM; Rothblat GH; Reilly MP
    Circulation; 2010 Mar; 121(11):1347-55. PubMed ID: 20212278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis.
    Brunham LR; Singaraja RR; Duong M; Timmins JM; Fievet C; Bissada N; Kang MH; Samra A; Fruchart JC; McManus B; Staels B; Parks JS; Hayden MR
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):548-54. PubMed ID: 19201688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism.
    Chung S; Timmins JM; Duong M; Degirolamo C; Rong S; Sawyer JK; Singaraja RR; Hayden MR; Maeda N; Rudel LL; Shelness GS; Parks JS
    J Biol Chem; 2010 Apr; 285(16):12197-209. PubMed ID: 20178985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.
    Zannis VI; Chroni A; Krieger M
    J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.